US Based Company Produced Cholestifin Drops for Normalizing Cholesterol

Levels

Cholestifin is a liquid for oral use, intended to normalize cholesterol levels.

Uniondale, NY, September 04, 2017 --(PR.com)-- American company manufactured Cholestifin, that is
intended to normalize cholesterol levels in human's body. The supplement is produced in liquid form, and
is sold in 50 ml bottle. The product is already available online and will be sold at a lower price the first
couple of days.

Beta-glucan, Hawthorn, Omega - 3 and L-carnitine are the active ingredients in Cholestifin's formula.
Beta-glucan is widely used in medicine. It is usually prescribed to patients, suffering from high
cholesterol, diabetes etc. When given by injection, beta-glucan might stimulate the immune system.
Omega 3 fats have numerous of health benefits. The most common medical conditions that consuming
more omega-3 foods have been prescribed for include high cholesterol, depression, anxiety,
inflammation, arthritis, diabetes. L-carnitine is an amino acid derivative that is produced in the body, but
it is also available as a supplement. It is used for conditions of the heart and blood vessels including
heart-related chest pain, heart attack, leg pain caused by circulation problems, and high cholesterol.
Hawthorn is a plant, usually used to promote the health of the circulatory system, treat high blood
pressure, and cardiac arrhythmia. It is also applied in patients with high levels of harmful cholesterol.

CDC (Centers for Disease Control -

https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_cholesterol.htm) announces that 71 million
American adults (33.5%) have high low-density lipoprotein (LDL), or bad cholesterol. This condition
could be quite dangerous, so it should be treated in any case. Treatment include medicines, prescribed by
0 physician, changes in lifestyle and diet, and >ptimal physical activity.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Cholestifin LLC
Mariah Evans
203-807-0768
Contact via Email
www.cholestifin.com

Online Version of Press Release:

You can read the online version of this press release at: http://www.pr.com/press-release/728801

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use